Cargando…

Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis

PURPOSE: The main objective of our meta-analysis was to examine the in vitro synergistic effect of meropenem-based combination therapies against Acinetobacter baumannii through a systematic review of the existing literature. METHODS: An extensive search was performed with no restrictions on date of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Zhihui, He, Xianxia, Li, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086107/ https://www.ncbi.nlm.nih.gov/pubmed/30122965 http://dx.doi.org/10.2147/IDR.S172137

Ejemplares similares

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2021)

1542. The Evaluation of the In Vitro Synergy of Colistin in Combination with Meropenem and Tigecycline against 50 Multi-Drug-resistant Acinetobacter baumannii strains
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
por: Dahdouh, E., et al.
Publicado: (2014)

Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant Acinetobacter baumannii
por: Zhu, Shixing, et al.
Publicado: (2022)

Effect of combined colistin and meropenem against meropenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa by checkerboard method: A cross sectional analytical study
por: Gunalan, Anitha, et al.
Publicado: (2021)

Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure
por: Rivani, Erizka, et al.
Publicado: (2022)

The Role of Uniform Meropenem Usage in Acinetobacter baumannii Clone Replacement
por: Balázs, Bence, et al.
Publicado: (2021)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Park, Jae-Min, et al.
Publicado: (2021)

Multidrug-resistant Acinetobacter baumannii strains with NDM-1: Molecular characterization and in vitro efficacy of meropenem-based combinations
por: Wang, Jingjing, et al.
Publicado: (2019)

Curcumin-meropenem synergy in carbapenem resistant Klebsiella pneumoniae curcumin-meropenem synergy
por: Gülen, Dumrul, et al.
Publicado: (2021)

The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant Acinetobacter baumannii
por: Zhang, Jiayuan, et al.
Publicado: (2022)

In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii
por: Ju, Yong Guk, et al.
Publicado: (2022)

Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro
por: Güran, Mümtaz, et al.
Publicado: (2023)

Virulence of Acinetobacter baumannii Exhibiting Phenotypic Heterogeneous Growth against Meropenem in a Murine Thigh Infection Model
por: Neou, Evangelia, et al.
Publicado: (2013)

An Outer Membrane Protein YiaD Contributes to Adaptive Resistance of Meropenem in Acinetobacter baumannii
por: Han, Lei, et al.
Publicado: (2022)

Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019)

Blue Light Sensing BlsA-Mediated Modulation of Meropenem Resistance and Biofilm Formation in Acinetobacter baumannii
por: Yang, Jihye, et al.
Publicado: (2023)

Computational exploration of molecular flexibility and interaction of meropenem analogs with the active site of oxacillinase-23 in Acinetobacter baumannii
por: Ramachandran, Balajee, et al.
Publicado: (2023)

Evaluation of synergistic effect of tazobactam with meropenem and ciprofloxacin against multi-drug resistant Acinetobacter baumannii isolated from burn patients in Tehran
por: Valadan Tahbaz, Sahel, et al.
Publicado: (2019)

Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant Acinetobacter baumannii
por: Karakonstantis, Stamatis, et al.
Publicado: (2021)

Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii
por: Phee, Lynette M, et al.
Publicado: (2019)

Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
por: Gaurav, Amit, et al.
Publicado: (2021)

Impact of minocycline, polymyxin B, meropenem, and amikacin on growth-prevention of Acinetobacter baumannii with various biofilm-forming capabilities
por: Beganovic, Maya, et al.
Publicado: (2017)

Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model
por: Fan, Bing, et al.
Publicado: (2016)

Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis
por: Chu, Haiqing, et al.
Publicado: (2013)

In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii
por: Gill, Christian M, et al.
Publicado: (2023)

Antimicrobial Efficacy and Synergy of Metal Ions against Enterococcus faecium, Klebsiella pneumoniae and Acinetobacter baumannii in Planktonic and Biofilm Phenotypes
por: Vaidya, Misha Y., et al.
Publicado: (2017)

Two Phenotype-Differentiated Acinetobacter baumannii Mutants That Survived in a Meropenem Selection Display Large Differences in Their Transcription Profiles
por: Gao, Qianqian, et al.
Publicado: (2019)

Severe Community-acquired Pneumonia Caused by Acinetobacter baumannii Successfully Treated with the Initial Administration of Meropenem Based on the Sputum Gram Staining Findings
por: Iwasawa, Yurika, et al.
Publicado: (2018)

Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against Acinetobacter baumannii strains in terms of bactericidal efficacy and resistance selection
por: Fetiye, Kolayli, et al.
Publicado: (2004)

Synergistic Effect of Colistin and Rifampin Against Multidrug Resistant Acinetobacter baumannii: A Systematic Review and Meta-Analysis
por: Mohammadi, Maryam, et al.
Publicado: (2017)

Therapeutic drug monitoring-guided high dose meropenem therapy of a multidrug resistant Acinetobacter baumannii - A case report
por: Liebchen, U., et al.
Publicado: (2019)

Correlation between Acinetobacter baumannii Resistance and Hospital Use of Meropenem, Cefepime, and Ciprofloxacin: Time Series Analysis and Dynamic Regression Models
por: Kousovista, Rania, et al.
Publicado: (2021)

Metabolic Analyses Revealed Time-Dependent Synergistic Killing by Colistin and Aztreonam Combination Against Multidrug-Resistant Acinetobacter baumannii
por: Han, Mei-Ling, et al.
Publicado: (2018)

The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit
por: Ceccarelli, Giancarlo, et al.
Publicado: (2015)

Antimicrobial Resistance of Acinetobacter baumannii to Imipenem in Iran: A Systematic Review and Meta-Analysis
por: Pourhajibagher, Maryam, et al.
Publicado: (2016)

In vitro and in vivo synergistic effect of chrysin in combination with colistin against Acinetobacter baumannii
por: Zhao, Yining, et al.
Publicado: (2022)

Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens
por: Dillon, Nicholas, et al.
Publicado: (2019)

Potential Synergy Activity of the Novel Ceragenin, CSA-13, against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Bacteremia Patients
por: Bozkurt-Guzel, Cagla, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j8drth5lmv1s521pbsj8eg4qh6